These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. Dashwood MR; Savage K; Tsui JC; Dooley A; Shaw SG; Fernández Alfonso MS; Bodin L; Souza DS J Thorac Cardiovasc Surg; 2009 Aug; 138(2):334-40. PubMed ID: 19619776 [TBL] [Abstract][Full Text] [Related]
4. Does periadventitial fat-derived nitric oxide play a role in improved saphenous vein graft patency in patients undergoing coronary artery bypass surgery? Dashwood MR; Dooley A; Shi-Wen X; Abraham DJ; Souza DS J Vasc Res; 2007; 44(3):175-81. PubMed ID: 17308436 [TBL] [Abstract][Full Text] [Related]
5. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. Khaleel MS; Dorheim TA; Duryee MJ; Durbin HE; Bussey WD; Garvin RP; Klassen LW; Thiele GM; Anderson DR Ann Thorac Surg; 2012 Feb; 93(2):552-8. PubMed ID: 22206954 [TBL] [Abstract][Full Text] [Related]
6. Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production. Dashwood MR; Savage K; Dooley A; Shi-Wen X; Abraham DJ; Souza DS Ann Thorac Surg; 2005 Sep; 80(3):939-44. PubMed ID: 16122459 [TBL] [Abstract][Full Text] [Related]
7. Does a 'no-touch' technique result in better vein patency? Sepehripour AH; Jarral OA; Shipolini AR; McCormack DJ Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):626-30. PubMed ID: 21908888 [TBL] [Abstract][Full Text] [Related]
8. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart. Czibik G; Wu Z; Berne GP; Tarkka M; Vaage J; Laurikka J; Järvinen O; Valen G Eur J Cardiothorac Surg; 2008 Nov; 34(5):976-84. PubMed ID: 18842422 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein. Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408 [TBL] [Abstract][Full Text] [Related]
10. Intermediate-term patency of saphenous vein graft with a clampless hand-sewn proximal anastomosis device after off-pump coronary bypass grafting. Shimokawa T; Manabe S; Sawada T; Matsuyama S; Fukui T; Takanashi S Ann Thorac Surg; 2009 May; 87(5):1416-20. PubMed ID: 19379877 [TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol in storage solution on adhesion molecule expression and nitric oxide synthesis in vein grafts. Kaplan S; Morgan JA; Bisleri G; Cheema FH; Akman HO; Topkara VK; Oz MC Ann Thorac Surg; 2005 Nov; 80(5):1773-8. PubMed ID: 16242454 [TBL] [Abstract][Full Text] [Related]
13. Comparison of conventional and no-touch techniques in harvesting saphenous vein for coronary artery bypass grafting in view of endothelial damage. Sen O; Gonca S; Solakoglu S; Dalcik H; Dalcik C; Ozkara A Heart Surg Forum; 2013 Aug; 16(4):E177-83. PubMed ID: 23958526 [TBL] [Abstract][Full Text] [Related]
14. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a 'no-touch' technique. Tsui JC; Souza DS; Filbey D; Bomfim V; Dashwood MR Br J Surg; 2001 Sep; 88(9):1209-15. PubMed ID: 11531869 [TBL] [Abstract][Full Text] [Related]
15. Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial. Desai ND; Naylor CD; Kiss A; Cohen EA; Feder-Elituv R; Miwa S; Radhakrishnan S; Dubbin J; Schwartz L; Fremes SE; Circulation; 2007 Feb; 115(6):684-91. PubMed ID: 17283268 [TBL] [Abstract][Full Text] [Related]
16. Influence of pressure on the endothelium of the saphenous vein coronary artery bypass graft. Dumanski A; Sopel M; Pelczar M; Szłapka M; Kustrzycki W; Zabel M In Vivo; 2007; 21(5):785-9. PubMed ID: 18019412 [TBL] [Abstract][Full Text] [Related]
17. Structural, biochemical and functional effects of distending pressure in the human saphenous vein: implications for bypass grafting. Chester AH; Buttery LD; Borland JA; Springall DR; Rothery S; Severs NJ; Polak JM; Yacoub MH Coron Artery Dis; 1998; 9(2-3):143-51. PubMed ID: 9647416 [TBL] [Abstract][Full Text] [Related]
18. Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells. Weber NC; Kandler J; Schlack W; Grueber Y; Frädorf J; Preckel B Anesthesiology; 2008 Feb; 108(2):199-207. PubMed ID: 18212564 [TBL] [Abstract][Full Text] [Related]
19. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Rousou LJ; Taylor KB; Lu XG; Healey N; Crittenden MD; Khuri SF; Thatte HS Ann Thorac Surg; 2009 Jan; 87(1):62-70. PubMed ID: 19101270 [TBL] [Abstract][Full Text] [Related]
20. Endothelial preservation of the minimally manipulated saphenous vein composite graft: histologic and immunohistochemical study. Hwang HY; Kim MA; Seo JW; Kim KB J Thorac Cardiovasc Surg; 2012 Sep; 144(3):690-6. PubMed ID: 22306225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]